Prevalência e fatores associados à bacteremia nos portadores de colecistite aguda litiásica

Baitello, André Luciano; Neto, Ramiro Colleoni; Filho, Benedito Herani; Cordeiro, José Antônio; Machado, Antonia M O; Godoy, Moacir Fernandes de; Gaia, Felipe

doi:10.1590/s0104-42302004000400025

Cited by 7 publications

(4 citation statements)

References 37 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…On the other hand, previous studies indicated that positive rates of blood cultures among patients with acute cholangitis ranged from 21 to 71 % [3]. For acute cholecystitis, the prevalence of positive blood cultures is less than acute cholangitis, and in the last two decades it has been reported to range from 7.7 to 15.8 % [28, 31]. Table 2 shows the most recently reported microbial isolates from patients with bacteremic biliary tract infections [14, ].…”

Section: Clinical Questionsmentioning

confidence: 99%

See 1 more Smart Citation

TG13 antimicrobial therapy for acute cholangitis and cholecystitis

Gomi

Solomkin

Takada

et al. 2013

J Hepato Biliary Pancreat

132

133

View full text Add to dashboard Cite

Therapy with appropriate antimicrobial agents is an important component in the management of patients with acute cholangitis and/or acute cholecystitis. In the updated Tokyo Guidelines (TG13), we recommend antimicrobial agents that are suitable from a global perspective for management of these infections. These recommendations focus primarily on empirical therapy (presumptive therapy), provided before the infecting isolates are identified. Such therapy depends upon knowledge of both local microbial epidemiology and patient-specific factors that affect selection of appropriate agents. These patient-specific factors include prior contact with the health care system, and we separate community-acquired versus healthcare-associated infections because of the higher risk of resistance in the latter. Selection of agents for community-acquired infections is also recommended on the basis of severity (grades I-III).Free full-text articles and a mobile application of TG13 are available via

show abstract

Section: Clinical Questionsmentioning

confidence: 99%

“…The bacteria commonly found in biliary tract infections are well known, and are presented in Tables 1 and 2 [3,4,[20][21][22][23][24][25][26][27][28][29][30][31]. Antimicrobial therapy largely depends on local antimicrobial susceptibility data.…”

Section: Introductionmentioning

confidence: 99%

TG13 antimicrobial therapy for acute cholangitis and cholecystitis

Gomi

Solomkin

Takada

et al. 2013

J Hepato Biliary Pancreat

132

133

View full text Add to dashboard Cite

show abstract

“…A recent multicenter study of patients with acute cholangitis showed the proportions of positive blood cultures were 15.2%, 21%, and 25.7% by TG13 severity grade I, II, and III, respectively . For acute cholecystitis, the prevalence of positive blood cultures is less than acute cholangitis, and in the last two decades it has been reported to range from 7.7% to 15.8% . Table demonstrates the most recently reported microbial isolates from patients with bacteremic biliary tract infections .…”

Section: Clinical Questionsmentioning

confidence: 99%

“…The bacteria commonly found in biliary tract infections are well known, and are presented in Tables and . A large‐scale multicenter international observational study was conducted and published in 2017 on epidemiology and microbiology among patients with acute cholangitis .…”

Section: Introductionmentioning

confidence: 99%

Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis

Gomi

Solomkin

Schlossberg

et al. 2018

J Hepato Biliary Pancreat

299

249

View full text Add to dashboard Cite

Antimicrobial therapy is a mainstay of the management for patients with acute cholangitis and/or cholecystitis. The Tokyo Guidelines 2018 (TG18) provides recommendations for the appropriate use of antimicrobials for community-acquired and healthcare-associated infections. The listed agents are for empirical therapy provided before the infecting isolates are identified. Antimicrobial agents are listed by classdefinitions and TG18 severity grade I, II, and III subcategorized by clinical settings. In the era of emerging and increasing antimicrobial resistance, monitoring and updating local antibiograms is underscored. Prudent antimicrobial usage and early de-escalation or termination of antimicrobial therapy are now important parts of decision-making. What is new in TG18 is that the duration of antimicrobial therapy for both acute cholangitis and cholecystitis is systematically reviewed. Prophylactic antimicrobial usage for elective endoscopic retrograde cholangiopancreatography is no longer recommended and the section was deleted in TG18. Free full articles and mobile app of TG18 are available at: http://www.jshbps.jp/modules/en/index.php?content_id=47. Related clinical questions and references are also included.

show abstract

Perialveolar bacterial microbiota and bacteraemia after dental alveolitis in adult rats that had been subjected to neonatal malnutrition

et al. 2011

View full text Add to dashboard Cite

The aim of the present study was to analyse the bacteriological factors during the process of dental alveolitis, relating it to a higher incidence of bacteraemia in adult rats subjected to neonatal malnutrition. We used forty male Wistar rats, suckled by mothers fed a diet during lactation containing 17 % protein in the nourished group (N) or 8 % protein in the undernourished group (UN). After weaning, the animals were given the Labina standard diet. After 90 d, these animals underwent upper right incisor extraction and induction of alveolitis. The oral microbiota was obtained using a swab and blood culture through venous blood. These procedures were performed before the extraction, 5 min after extraction, on the 21st day after alveolitis for groups N-21 and UN-21 and on the 28th day after alveolitis for groups N-28 and UN-28. Data were expressed as means and standard deviations for parametric data, and as medians and interquartile intervals for non-parametric data. Statistical significance was considered by assuming a critical level of 5 %. Before and after extraction, lower bacterial growth was observed per colony-forming unit (CFU) in the perialveolar region of the upper right incisors of undernourished animals, while the opposite was true after alveolitis, when a larger number of CFU was observed in these animals. The percentage of positive blood cultures obtained after alveolitis was greater in the undernourished animals. The present study thus demonstrated the influence of neonatal malnutrition in the perialveolar microbiota and in the development of bacteraemia after dental alveolitis.

show abstract

Prevalência e fatores associados à bacteremia nos portadores de colecistite aguda litiásica

Cited by 7 publications

References 37 publications

TG13 antimicrobial therapy for acute cholangitis and cholecystitis

TG13 antimicrobial therapy for acute cholangitis and cholecystitis

Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis

Perialveolar bacterial microbiota and bacteraemia after dental alveolitis in adult rats that had been subjected to neonatal malnutrition

Contact Info

Product

Resources

About